PERFLUOROCARBON BLOOD SUBSTITUTES

被引:76
作者
BIRO, GP
BLAIS, P
机构
[1] HLTH & WELF CANADA,BUR MED DEVICES,OTTAWA K1A 0L2,ONTARIO,CANADA
[2] UNIV MONTREAL,FAC MED,DEPT COMMUNITY HLTH,MONTREAL H3C 3J7,QUEBEC,CANADA
来源
CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY | 1987年 / 6卷 / 04期
关键词
D O I
10.1016/S1040-8428(87)80018-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:311 / 374
页数:64
相关论文
共 245 条
  • [1] LIPOSOME DISPOSITION INVIVO .3. DOSE AND VESICLE-SIZE EFFECTS
    ABRA, RM
    HUNT, CA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 666 (03) : 493 - 503
  • [2] ADAMS JE, 1959, SURG FORUM, V10, P585
  • [3] AGISHI T, 1984, T AM SOC ART INT ORG, V30, P295
  • [4] AGISHI T, 1983, T AM SOC ART INT ORG, V29, P456
  • [5] AKIMURA H, 1978, PLASTIC AGE, V24, P75
  • [6] ALEXANDER B, 1975, FED PROC, V34, P1429
  • [7] ALEXANDER B, 1978, BLOOD SUBSTITUTES PL, P293
  • [8] ANDERSON RM, 1970, T AM SOC ART INT ORG, V16, P375
  • [9] ANGEL JA, 1983, PHYSICIAN DESK REFER
  • [10] GAS CHROMATOGRAPHY-MASS SPECTROMETRY OF FLUOROCARBONS 11 AND 12 IN BIOLOGIC SPECIMENS
    BACKER, RC
    PISANO, RV
    [J]. CLINICAL TOXICOLOGY, 1978, 12 (01): : 69 - 75